Sign in

CIK 0001867096

  • Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
871082097
Phone
+1 844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Other acquisition Director acquired 89,571 shares (other)
  2. 4 Exercise or conversion Director acquired 215,600 shares (option exercise)
  3. 4 Open-market buy Director bought 4,500 shares at $2.16 ($9,720)
  4. 4 Grant or award Pieper Steven acquired 450,000 shares (grant or award)
  5. 4 Grant or award Shannon John Patrick Jr acquired 750,000 shares (grant or award)
  6. 4 Grant or award JOHNSON KENNETH ERLAND acquired 175,000 shares (grant or award)
  7. 4 Grant or award Hecht Beth acquired 750,000 shares (grant or award)
  8. 4 Grant or award Edick Paul R acquired 1,500,000 shares (grant or award)
  9. 4 Open-market buy Director bought 5,400 shares at $1.87 ($10,098)
  10. 4 Open-market buy Director bought 5,410 shares at $1.84 ($9,954)
  11. 4 Open-market buy Pieper Steven bought 28,000 shares at $1.95 ($54,600)
  12. 4 Open-market buy Director bought 6,500 shares at $1.51 ($9,815)
  13. 4 Open-market buy Shannon John Patrick Jr bought 30,769 shares at $1.64 ($50,400)
  14. 4 Open-market buy Director bought 6,370 shares at $1.58 ($10,058)
  15. 4 Open-market buy Edick Paul R bought 10,000 shares at $2.38 ($23,794)
  16. 4 Grant or award Director acquired 42,500 shares (grant or award)
  17. 4 Grant or award Director acquired 42,500 shares (grant or award)
  18. 4 Grant or award Director acquired 42,500 shares (grant or award)
  19. 4 Grant or award Director acquired 42,500 shares (grant or award)
  20. 4 Grant or award Director acquired 42,500 shares (grant or award)

Page 6 of 9 · 178 filings